David M. Swoboda, MD, and Andrew Kuykendall, MD, spoke about the current treatment strategies and potential advancements that may improve outcomes such as spleen volume reduction in the myelofibrosis field.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
Fred Hutch public health researchers Drs. Scott Ramsey and Veena Shankaran welcomed stakeholders to the 2024 Value in Cancer Care Summit held November 15, thanking…
Chemotherapy toxicity tools are rarely studied in patients with hematologic malignancy (HM). The primary aim of this pilot study was to determine the predictive ability…
212Pb-DOTAMTATE demonstrated activity and was considered well tolerated in patients with unresectable or metastatic SSTR+ GEP-NETs who had not received prior PRRT.
This clinical insights article is derived from recommendations in Management of Stage III Non-Small Cell Lung Cancer: ASCO Rapid Guideline Update. This document is based…
One of the prime risk factors for CRC is the consumption of a high-risk, Western-style diet high in processed foods, refined grains, red meat, and…
The addition of T4001, an investigation cancer vaccine, to avelumab did not improve progression-free survival vs avelumab alone in cervical and anogenital tumors.
Learn more about when and how to register for the December 2024 ASTRO Coding and Coverage Seminar
Edited and introduced by Associate Editor Thomas Ortel, this review series features 3 reviews of von Willebrand factor, factor VIII, and factor IX. These 3
Welcome! You are invited to join a webinar: SSO CGSO Videoconference: Career Discussions in Surgical Oncology. After registering, you will receive a confirmation email about…
